The Benefits of Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma Require at Least Three Cycles-Reference-Cited by-同舟云学术

The Benefits of Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma Require at Least Three Cycles

Published:2024 Issue:3 Volume:67 Page:183-190
ISSN:1346-8049
Container-title:Yonago Acta Medica
language:en
Short-container-title:Yonago Acta Med.

Author:

Yumioka Tetsuya¹,Morizane Shuichi²,Muraoka Kuniyasu³,Oono Hirofumi¹,Isoyama Tadahiro⁴,Sakaridani Naoyuki⁵,Ono Koji⁶,Sejima Takehiro⁷,Kadowaki Hiroyuki⁸,Hikita Katsuya²,Honda Masashi²,Takenaka Atsushi²

Affiliation:

1. Department of Urology, Matsue Red Cross Hospital, Matsue 690-8506, Japan

2. Division of Urology, Department of Surgery, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan

3. Department of Urology, Tottori Prefectural Central Hospital, Tottori 680-0901, Japan

4. Department of Urology, Yonago Medical Center, Yonago 683-0006, Japan

5. Department of Urology, Hamada Medical Center, Hamada 697-8511, Japan

6. Department of Urology, Tottori Red Cross Hospital, Tottori 680-8517, Japan

7. Department of Urology, Matsue City Hospital, Matsue 690-8509, Japan

8. Department of Urology, Sanin Rosai Hospital, Yonago 683-8605, Japan

Publisher

Tottori University Faculty of Medicine

Link

https://www.jstage.jst.go.jp/article/yam/67/3/67_2024.08.001/_pdf

Reference24 articles.

1. 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30. PMID:29313949, DOI:10.3322/caac.21442

2. 2. Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, et al.; Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma Collaboration. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224-33. PMID:19156917, DOI:10.1002/cncr.24135

3. 3. Siefker-Radtke AO, Dinney CP, Abrahams NA, Moran C, Shen YU, Pisters LL, et al. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J Urol. 2004;172:481-4. PMID:15247709, DOI:10.1097/01.ju.0000132413.85866.fc

4. 4. Birtle A, Johnson M, Chester J, Jones R, Dolling D, Bryan RT, et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. 2020;395:1268-77. PMID:32145825, DOI:10.1016/S0140-6736(20)30415-3

5. 5. Rouprêt M, Seisen T, Birtle AJ, Capoun O, Compérat EM, Dominguez-Escrig JL, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update. Eur Urol. 2023;84:49-64. PMID:36967359, DOI:10.1016/j.eururo.2023.03.013